Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
1000+ Ergebnisse
| UR13TE |  | BioNTech SE (ADRs)/OS/Call [154]/UniCredit | - | - | 154,000 | call | BioNTech SE (ADRs) | - | 50,931 % | 0,233 | -0,014 | 4,400 | 16.06.2027 | 0,100 | Unicredit | |
| PK0216 | | BioNTech SE (ADRs)/OS/Call [155]/BNP | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 90,861 % | 0,113 | -0,033 | 6,527 | 18.09.2026 | 0,100 | BNP Paribas | |
| DU7JDM | BioNTech SE (ADRs)/OS/Call [155]/DZ | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 83,451 % | 0,088 | -0,025 | 7,350 | 18.09.2026 | 0,100 | DZ Bank | ||
| DU7JDN | BioNTech SE (ADRs)/OS/Call [155]/DZ | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 57,884 % | 0,125 | -0,015 | 6,316 | 18.12.2026 | 0,100 | DZ Bank | ||
| JZ7EQP | BioNTech SE (ADRs)/OS/Call [155]/JPMD | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 56,150 % | 0,144 | -0,015 | 5,850 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE7TM1 | BioNTech SE (ADRs)/OS/Call [155]/JPMD | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 56,022 % | 0,114 | -0,014 | 6,608 | 18.12.2026 | 0,100 | JP Morgan | ||
| JY2YM0 | BioNTech SE (ADRs)/OS/Call [155]/JPMD | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 52,372 % | 0,175 | -0,014 | 5,239 | 19.03.2027 | 0,100 | JP Morgan | ||
| MJ5PPK | | BioNTech SE (ADRs)/OS/Call [155]/MS | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 74,719 % | 0,213 | -0,028 | 4,543 | 18.12.2026 | 0,100 | Morgan Stanley | |
| UR0HS6 | | BioNTech SE (ADRs)/OS/Call [155]/UniCredit | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 57,373 % | 0,149 | -0,016 | 5,735 | 13.01.2027 | 0,100 | Unicredit | |
| UR0HS7 | | BioNTech SE (ADRs)/OS/Call [155]/UniCredit | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 50,903 % | 0,229 | -0,014 | 4,423 | 16.06.2027 | 0,100 | Unicredit | |
| VH2FWQ | | BioNTech SE (ADRs)/OS/Call [155]/VONT | - | - | 155,000 | call | BioNTech SE (ADRs) | - | 53,559 % | 0,129 | -0,013 | 6,230 | 15.01.2027 | 0,100 | Vontobel | |
| MK7GWM | | BioNTech SE (ADRs)/OS/Call [156]/MS | - | - | 156,000 | call | BioNTech SE (ADRs) | - | 75,294 % | 0,212 | -0,028 | 4,520 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM8J9F | | BioNTech SE (ADRs)/OS/Call [156]/MS | - | - | 156,000 | call | BioNTech SE (ADRs) | - | 65,786 % | 0,323 | -0,021 | 3,303 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM8JVV | | BioNTech SE (ADRs)/OS/Call [156]/MS | - | - | 156,000 | call | BioNTech SE (ADRs) | - | 70,348 % | 0,047 | -0,013 | 9,463 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN7KQU | | BioNTech SE (ADRs)/OS/Call [156]/MS | - | - | 156,000 | call | BioNTech SE (ADRs) | - | 69,636 % | 0,277 | -0,024 | 3,725 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR0X97 | | BioNTech SE (ADRs)/OS/Call [156]/MS | - | - | 156,000 | call | BioNTech SE (ADRs) | - | 71,950 % | 0,451 | -0,020 | 2,394 | 17.12.2027 | 0,100 | Morgan Stanley | |
| UR13TF | | BioNTech SE (ADRs)/OS/Call [158]/UniCredit | - | - | 158,000 | call | BioNTech SE (ADRs) | - | 51,214 % | 0,220 | -0,014 | 4,448 | 16.06.2027 | 0,100 | Unicredit | |
| PG956S | | BioNTech SE (ADRs)/OS/Call [160]/BNP | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 55,311 % | 0,094 | -0,012 | 6,924 | 18.12.2026 | 0,100 | BNP Paribas | |
| PG956Z | | BioNTech SE (ADRs)/OS/Call [160]/BNP | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 54,398 % | 0,116 | -0,012 | 6,275 | 15.01.2027 | 0,100 | BNP Paribas | |
| PL6QZ2 | | BioNTech SE (ADRs)/OS/Call [160]/BNP | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 85,897 % | 0,082 | -0,024 | 7,261 | 18.09.2026 | 0,100 | BNP Paribas | |
| PK6Q9N | | BioNTech SE (ADRs)/OS/Call [160]/BNP | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 51,907 % | 0,154 | -0,013 | 5,427 | 19.03.2027 | 0,100 | BNP Paribas | |
| PK6Q9Q | | BioNTech SE (ADRs)/OS/Call [160]/BNP | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 52,555 % | 0,317 | -0,014 | 3,332 | 17.12.2027 | 0,100 | BNP Paribas | |
| PK6Q9S | | BioNTech SE (ADRs)/OS/Call [160]/BNP | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 52,249 % | 0,330 | -0,013 | 3,227 | 21.01.2028 | 0,100 | BNP Paribas | |
| PK6Q9U | | BioNTech SE (ADRs)/OS/Call [160]/BNP | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 51,642 % | 0,347 | -0,013 | 3,094 | 17.03.2028 | 0,100 | BNP Paribas | |
| DU7K1K | BioNTech SE (ADRs)/OS/Call [160]/DZ | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 58,413 % | 0,111 | -0,014 | 6,411 | 18.12.2026 | 0,100 | DZ Bank | ||
| DU7K1J | BioNTech SE (ADRs)/OS/Call [160]/DZ | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 86,079 % | 0,082 | -0,025 | 7,240 | 18.09.2026 | 0,100 | DZ Bank | ||
| GW2DR0 | BioNTech SE (ADRs)/OS/Call [160]/GOLDS | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 63,176 % | 0,165 | -0,018 | 5,149 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW2DTD | BioNTech SE (ADRs)/OS/Call [160]/GOLDS | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 102,285 % | 0,134 | -0,042 | 5,706 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GW6138 | BioNTech SE (ADRs)/OS/Call [160]/GOLDS | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 65,147 % | 0,144 | -0,019 | 5,549 | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GW95H2 | BioNTech SE (ADRs)/OS/Call [160]/GOLDS | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 135,900 % | 0,119 | -0,068 | 6,026 | 21.08.2026 | 0,100 | Goldman Sachs | ||
| HS4PU6 | BioNTech SE (ADRs)/OS/Call [160]/HSBC | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 53,759 % | 0,112 | -0,012 | 6,377 | 15.01.2027 | 0,100 | HSBC | ||
| HT1PNV | BioNTech SE (ADRs)/OS/Call [160]/HSBC | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 50,703 % | 0,315 | -0,013 | 3,342 | 21.01.2028 | 0,100 | HSBC | ||
| HT1PNQ | BioNTech SE (ADRs)/OS/Call [160]/HSBC | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 51,989 % | 0,077 | -0,009 | 7,557 | 18.12.2026 | 0,100 | HSBC | ||
| HM20R7 | BioNTech SE (ADRs)/OS/Call [160]/HSBC | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 50,484 % | 0,301 | -0,013 | 3,484 | 17.12.2027 | 0,100 | HSBC | ||
| HM2ZSK | BioNTech SE (ADRs)/OS/Call [160]/HSBC | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 50,502 % | 0,145 | -0,012 | 5,620 | 19.03.2027 | 0,100 | HSBC | ||
| HM2ZSS | BioNTech SE (ADRs)/OS/Call [160]/HSBC | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 50,310 % | 0,435 | -0,011 | 2,539 | 19.01.2029 | 0,100 | HSBC | ||
| HM605R | BioNTech SE (ADRs)/OS/Call [160]/HSBC | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 49,991 % | 0,205 | -0,013 | 4,609 | 17.06.2027 | 0,100 | HSBC | ||
| JZ67ST | BioNTech SE (ADRs)/OS/Call [160]/JPMD | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 56,168 % | 0,126 | -0,014 | 6,010 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY3064 | BioNTech SE (ADRs)/OS/Call [160]/JPMD | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 51,916 % | 0,154 | -0,013 | 5,426 | 19.03.2027 | 0,100 | JP Morgan | ||
| MJ3R9L | | BioNTech SE (ADRs)/OS/Call [160]/MS | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 77,027 % | 0,204 | -0,028 | 4,476 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM01NK | | BioNTech SE (ADRs)/OS/Call [160]/MS | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 66,379 % | 0,314 | -0,021 | 3,308 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM7KFY | | BioNTech SE (ADRs)/OS/Call [160]/MS | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 95,970 % | 0,112 | -0,035 | 6,236 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN1LZS | | BioNTech SE (ADRs)/OS/Call [160]/MS | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 72,260 % | 0,442 | -0,020 | 2,406 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN8486 | | BioNTech SE (ADRs)/OS/Call [160]/MS | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 70,713 % | 0,270 | -0,024 | 3,707 | 19.03.2027 | 0,100 | Morgan Stanley | |
| SJ6MPS | BioNTech SE (ADRs)/OS/Call [160]/SOC | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 65,530 % | 0,027 | -0,007 | 10,869 | 18.09.2026 | 0,100 | Société Générale | ||
| UG9FU8 | | BioNTech SE (ADRs)/OS/Call [160]/UniCredit | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 55,694 % | 0,094 | -0,012 | 6,923 | 16.12.2026 | 0,100 | Unicredit | |
| UG9H7Z | | BioNTech SE (ADRs)/OS/Call [160]/UniCredit | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 54,727 % | 0,116 | -0,013 | 6,274 | 13.01.2027 | 0,100 | Unicredit | |
| UN6SHL | | BioNTech SE (ADRs)/OS/Call [160]/UniCredit | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 51,496 % | 0,150 | -0,012 | 5,514 | 17.03.2027 | 0,100 | Unicredit | |
| UR05Y9 | | BioNTech SE (ADRs)/OS/Call [160]/UniCredit | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 51,077 % | 0,211 | -0,013 | 4,501 | 16.06.2027 | 0,100 | Unicredit | |
| VH2FWN | | BioNTech SE (ADRs)/OS/Call [160]/VONT | - | - | 160,000 | call | BioNTech SE (ADRs) | - | 54,234 % | 0,115 | -0,012 | 6,302 | 15.01.2027 | 0,100 | Vontobel |